Buprenorphine Sublingual C-Iii 72189-0582
Product NDC
72189-0582- Manufacturer
- Direct_rx
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- October 15, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA078633
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 8 mg/1 |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Packaging Options(1)
60 TABLET in 1 BOTTLE (72189-582-60)